Shine Investment Advisory Services’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$13K Hold
280
﹤0.01% 513
2020
Q2
$14K Hold
280
0.01% 506
2020
Q1
$13K Buy
280
+47
+20% +$2.51K 0.01% 484
2019
Q4
$14K Hold
233
0.01% 517
2019
Q3
$12K Hold
233
0.01% 523
2019
Q2
$12K Hold
233
0.01% 513
2019
Q1
$12K Hold
233
0.01% 523
2018
Q4
$11K Hold
233
0.01% 509
2018
Q3
$12K Hold
233
0.01% 499
2018
Q2
$12K Hold
233
0.01% 504
2018
Q1
$11K Hold
233
0.01% 511
2017
Q4
$10K Sell
233
-128
-35% -$5.91K 0.01% 530
2017
Q3
$18K Buy
361
+158
+78% +$8.02K 0.01% 461
2017
Q2
$11K Buy
+203
New +$10.8K 0.01% 504

Other funds holding GSK

Shine Investment Advisory Services's GSK Position: Q3 2020 in Review

Shine Investment Advisory Services held its GSK (GSK) position steady in Q3 2020 at 280 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

Shine Investment Advisory Services first reported a position in GSK in Q2 2017 and has held it in 14 quarters since. The position peaked at $18K in Q3 2017. 827 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

  • Shine Investment Advisory Services held 280 shares of GSK worth $13K as of Q3 2020.
  • Shine Investment Advisory Services left its GSK share count unchanged in Q3 2020.
  • GSK made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #513 holding.
  • Shine Investment Advisory Services first reported a position in GSK in Q2 2017 and has held it in 14 quarters since.
  • Shine Investment Advisory Services's GSK position peaked at $18K in Q3 2017.
  • 827 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.